Compare RAPP & BWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | RAPP | BWIN |
|---|---|---|
| Founded | 2022 | 2011 |
| Country | United States | United States |
| Employees | N/A | 5020 |
| Industry | | Specialty Insurers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2024 | N/A |
| Metric | RAPP | BWIN |
|---|---|---|
| Price | $38.48 | $23.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $48.50 | $30.43 |
| AVG Volume (30 Days) | 279.9K | ★ 1.8M |
| Earning Date | 05-08-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 24.34 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $36.36 |
| Revenue Next Year | N/A | $10.82 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.05 | $15.88 |
| 52 Week High | $42.27 | $43.25 |
| Indicator | RAPP | BWIN |
|---|---|---|
| Relative Strength Index (RSI) | 55.06 | 66.05 |
| Support Level | $33.54 | $23.35 |
| Resistance Level | $40.81 | $24.58 |
| Average True Range (ATR) | 2.26 | 1.26 |
| MACD | 0.05 | 0.40 |
| Stochastic Oscillator | 74.44 | 83.74 |
Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders. The company's portfolio of programs from its RAP technology platform includes RAP-219, an investigational small molecule being developed as a therapy for focal onset seizures, primary generalized tonic-clonic seizures, and bipolar mania. Additionally, it has two discovery-stage nicotinic acetylcholine receptor (nAChR) programs stemming from its RAP technology platform: one being developed for the treatment of chronic pain, and the second, being developed for the treatment of hearing disorders. Geographically, the company operates in the United States.
The Baldwin Insurance Group Inc is an insurance distribution company operating in the United States. The company provides commercial risk management, employee benefits, private risk management, and personal insurance solutions. It operates through three segments: Insurance Advisory Solutions, which focuses on commercial risk management and employee benefits; Underwriting, Capacity & Technology Solutions, which includes managing general agency operations, reinsurance brokerage, captive management, and technology-enabled insurance products; and Mainstreet Insurance Solutions, which offers personal, commercial, and life and health insurance products through community-based distribution channels.